Americans are Being Robbed: Siphoning Public Taxpayer Money and calling Thievery "Public Health" and "$cience"

This UNAPPROVED drug costs $700 per course, and the American government has apparently contracted to buy 1.7MILLION courses of the drug for an approximate $$$1.2BILLION DOLLARS

The Case of Molnupiravir: A Useless Drug Never Approved for Anything, Now with a Market Value of BILLIONS OF *public/taxpayer* DOLLARS

Molnupiravir (MOL new PIR a vir) is a nearly-worthless drug that has never been approved for anything (according to Drugs.com 2021 cited below), but your governments are about to burn MILLION$$$ and BILLION$$$ on it, just like they did years ago with another antiviral drug Tamiflu/oseltamivir, which is famously one of the most clinically worthless and dangerous drugs on the market.

Evidently, viral infections and the fear and ignorance around them have become a great way for drug companies to sell worthless drugs to their bribed politicians. If we spent that money on heath-promotion rather than fear-promotion, we’d be freer, stronger, healthier, and we’d emancipate ourselves from the mental slavery of fear, ignorance, and dependence.

Vitamin D is safer, cheaper, and more effective for a wide range of conditions including pain (video1), mood disorders, depression, anxiety (video2), improving barrier integrity against infections and allergies (video3), excess inflammation (video4), and viral infections such as HPV/warts, hepatitis C, HIV/AIDS (video5, in process, included below).

Data from Medscape (Oct2021, cited below)

According to a single study (ie, zero confirmation of results) which was never completed (ie, the study was terminated early for unclear reasons) conducted by the drug company Merck that makes the drug (ie, no independent research) and without any disclosure of adverse events (ie, impossible to calculate any risk-benefit ratio, which is the core fundamental tool/equation that doctors use to make decisions) and without any publication in a peer-reviewed journal (ie, all we have is an advertising press release from the company trying to sell the drug), the drug hardly provides any benefit to hardly sick (ie, “mild to moderate”) Cv19 patients. See summary table below; download/save and enlarge the image if necessary for clearer viewing.

The drug costs $700 per course, and the American government has apparently contracted with Merck to buy 1.7MILLION courses of the drug for an approximate $$$1.2BILLION DOLLARS.

In contrast to molnupiravir, vitamin D is safer, cheaper, and more effective for a wide range of conditions including pain (video1), mood disorders, depression, anxiety (video2), improving barrier integrity against infections and allergies (video3), excess inflammation (video4), and viral infections such as HPV/warts, hepatitis C, HIV/AIDS (video5, in process, included below), and is supported by decades of independent peer-reviewed research from multiple countries in leading top-tier international specialty professional journals.

Vitamin D is

1. safer,

2. cheaper at about $20 (instead of Molnupiravir’s $700),

3. more effective for a wide range of conditions including…

4. …pain (video1),

5. …mood disorders, depression, anxiety (video2),

6. …improving barrier integrity against infections and allergies (video3),

7. …excess inflammation (video4),

8. …viral infections such as HPV/warts, hepatitis C, HIV/AIDS (video5, in process, included below),

9. plus it is supported by independent peer-reviewed research from multiple countries in leading top-tier international specialty professional journals.

10. See the PDF compilation of DrV’s articles on vitamin D as published in British Medical Journal, JAMA, Journal of Clinical Endocrinology and Metabolism, Nutritional Perspectives and more!

I have a new video coming soon on “Vitamin D in the Treatment and Prevention of Viral Infections” (see sample below from the first edit) so be sure you are subscribed to the newsletter/website to get access to the full version when it becomes available.

---

VIDEO VitaminD’s Role in Immune Defense against Viruses: The Introduction (first 30 minutes, first edit)

See video at website; see video viewing instructions if necessary

**Note that all videos are visible on the website, and you can access the exact page of the website from the newsletter by clicking on the title of the newsletter above from within the email newsletter.

You can also always find the most recent newsletters at HealthyThinking.substack.com/archive

---

Sources on Molnupiravir:

1. Merck to Seek FDA OK for Its COVID Pill After Trial Stopped Early, Medscape October 01, 2021 medscape.com/viewarticle/960089

2. Merck Seeks FDA Authorization for Antiviral COVID-19 Pill, Medscape October 10, 2021 medscape.com/viewarticle/960638

3. "FDA Approved: No. ... Molnupiravir (EIDD-2801/MK-4482) is an investigational oral antiviral agent in development for the treatment of COVID-19." Molnupiravir FDA Approval Status Oct 1, 2021 drugs.com/history/molnupiravir.html

Sources on Vitamin D:

1. REVIEW no1: VITAMIN D DEFICIENCY results in CHRONIC PAIN and PAIN AMPLIFICATION

2. REVIEW no2: Vitamin D Deficiency in Mood Disorders, Anxiety, and Depression

3. REVIEW no3: Vitamin D in Physiology and Medicine, Part 3: Role in Barrier Defense

   1. Vitamin D for Strong Barrier Defenses, Prevention of Infection, and a Healthier Vagina?

4. REVIEW no4: Part 4 of my video series on “Redefining Vitamin D Deficiency in Adults” focuses on inflammation, excess blood coagulation, and the modulation or “balancing” of immune responses

5. Vitamin D treatment of severe hospitalized Cv19 in Journal of Clinical Endocrinology and Metabolism 2021 Jun

6. Vitamin D Levels in COVID-19 Outpatients, Clinical Effect of Supplementation

7. Vitamin D is Safe and Beneficial against Many Types of Human Papilloma Virus Infections

8. Quick Consult on Acute VitaminD Optimization

9. What is your vitamin D level? You need to know it now. Here are 2 images + 2 video excerpts + summary + recommended call to action

10. Research Designed to Fail: Effect of high-dose parenteral vitamin D3 on COVID-19-related inhospital mortality during intensive care unit admission. Eur J Clin Nutr 2021 July

Sources on Antiviral strategies and pandemic politics:

See the Antiviral Nutrition Course for more details

1. Antiviral Science is Standing Still or Going Backward, but We are Clearly NOT Moving Forward

2. FDA's hypocritical reversal on CV antibodies

3. Risk-Benefit Ratios of Cv19 Vaccinations 2021 June

4. ABSOLUTE (effectiveness) vs RELATIVE (efficacy) RISK REDUCTION in Research Reporting Bias

5. Pharmaceutical Bulldozer will Crush Us All if We Fail to Restrain It

6. Viral Mutations and Selenium Deficiency

7. Vitamin D treatment of severe hospitalized Cv19 in Journal of Clinical Endocrinology and Metabolism 2021 Jun

8. Life under Constant Surveillance, Permission, and Corporate Approval

9. You need to know V for Vendetta

10. AntiEducation amplified via Cv19 Reset

11. Leadership Knowledge Protects Society

12. Antiviral Nutrition VIDEO: Benefits of the amino acid (acetyl)Cysteine, NAC

13. Selenium promotes Antiviral Immunity, reduces Viral Mutation and Viral Replication: Excerpt from DrV's Clinical Protocol

14. We are 7 years late for my 2014 Antiviral Paradigm Shift: Let's catch up

15. Revisiting my 2019 "Pharma Echo Chamber, Sociopolitical Matrix, and Power Vortex" in 2020/2021 and Beyond

16. Vitamin D Levels in COVID-19 Outpatients, Clinical Effect of Supplementation

17. Carbon Dioxide Content in Inhaled Air With or Without Face Masks in Healthy Children" in JAMA Pediatrics published June 30, 2021

18. Vitamin D is Safe and Beneficial against Many Types of Human Papilloma Virus Infections

19. video update from your UNELECTED world controllers

20. "79% and 87%" is (or is not) 79% and 87%, depending on whether we are talking about low-cost low-risk multibenefit nutrition vs high-profit higher-risk drugs

This awesome newsletter is not personalized medical advice.

Send me a reply email if you have other data or a correction and I’ll reply and make any necessary (if necessary) updates.